A single nucleotide polymorphism rs553668 in the ADRA2A gene and the status of Polish elite endurance athletes

• Autorzy: Sawczuk M. , Maciejewska-Karlowska A. , Cieszczyk P.
• Języki publikacji: EN

Abstrakty

EN

Introduction. The variance in human athletic ability is the result of interaction of both genetic and environmental factors. The ADRA2A gene that encodes adrenergic receptors α2 is likely to be a candidate gene because ADRA2A receptors are crucial for precise cardiovascular control and are involved in the regulation of adipocyte lipolysis, glucose metabolism and insulin secretion. Several genetic variants of the ADRA2A gene have been identified, and one nucleotide polymorphism (SNP) rs553668 seems to be of special importance. On the basis of results of available studies it is assumed that the C allele of rs553668 might be associated with the status of Polish elite endurance athletes. Aim of the Study. The purposes of the study were to determine the distribution of the ADRA2A rs553668 SNP genotypes within a sample of Polish elite endurance athletes and sedentary controls to investigate a possible association between genetic polymorphisms in the ADRA2A gene and elite endurance athlete status and to check for an association between the rs553668 genotypes and alleles and the athlete status. Material and Methods. The study was performed on a group of 123 elite Polish endurance-oriented athletes. Control samples were prepared from 228 unrelated, sedentary volunteers. Results. No statistical differences were found between the endurance athletes and the control group across the ADRA2A C/T genotypes. Similarly, no statistical differences among the subgroups of top-elite, elite and sub-elite endurance athletes were observed. Conclusions.We found that the C allele as well as C-containing genotypes were not significantly more frequent in endurance athletes than in controls. This may suggest that harboring the T allele of the SNP rs553668 allele does not decrease the probability of being an endurance-oriented athlete in the Polish population. In respect to the analyzed population of Polish endurance athletes the ADRA2A gene can not be considered a candidate determinant of individual variations in exercise-related phenotypes.

Słowa kluczowe

EN

single nucleotide; polymorphism; rs553668 gene; ADRA2A gene; Poland; elite athlete; endurance; athlete; man; woman; cardiovascular function; control

• Wydawca: -
• Czasopismo: Trends in Sport Sciences
• Rocznik: 2013
• Tom: 20
• Numer: 1
• Opis fizyczny: p.30-35,ref.

Twórcy

autor

Sawczuk M.

• Department of Biological Bases of Physical Culture, University of Szczecin, Szczecin, Poland

autor

Maciejewska-Karlowska A.

• Department of Biological Bases of Physical Culture, University of Szczecin, Szczecin, Poland

autor

Cieszczyk P.

• Department of Biological Bases of Physical Culture, University of Szczecin, Szczecin, Poland

Bibliografia

• 1. Gibson WT. Key concepts in human genetics: under¬standing the complex phenotype. In: Borms J, Heb- belinck M, Hills AP, Noakes T, eds., Medicine and Sport Science, Vol. 54: Collins M, eds., Genetics and Sports, Basel: Karger AG; 2009. pp. 1-10.
• 2. Schoenfelder M. Genetics-based performance talent research: polymorphisms as predictors of endurance performance. J Appl Physiol. 2010; 108: 1454-1455.
• 3. Gilsbach R, Hein L. Are the pharmacology and physiol¬ogy of a2-adrenoceptors determined by a2-heterorecep- tors and autoreceptors respectively? Br J Pharmacol. 2012; 165: 90-102.
• 4. Small KM, Brown KM, Seman CA, et al. Complex hap- lotypes derived from noncoding polymorphisms of the intronless alpha2A-adrenergic gene diversify receptor expression. Proc Natl Acad Sci USA. 2006; 103: 5472¬5477.
• 5. Fukutake M, Hishimoto A, Nishiguchi N, et al. Associa¬tion of a2A-adrenergic receptor gene polymorphism with susceptibility to suicide in Japanese females. Prog Neuro- psychopharmacol Biol Psychiatry. 2008; 32: 1428-1433.
• 6. Gilsbach R, Schneider J, Lother A, et al. Sympathetic a2-adrenoceptors prevent cardiac hypertrophy and fi- brosis in mice at baseline but not after chronic pressure overload. Cardiovasc Res. 2010; 86: 432-444.
• 7. Lafontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res. 1993; 34: 1057-1091.
• 8. Rosengren AH, Jokubka R, Tojjar D, et al. Overexpres¬sion of alpha2A-adrenergic receptors contributes to type 2 diabetes. Science. 2010; 327: 217-220.
• 9. Lockette W, Ghosh S, Farrow S, et al. Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks. Am J Hypertens. 1995; 8: 390-394.
• 10. Bo S, Cassader M, Cavallo-Perin P, et al. The rs553668 polymorphism of the ADRA2A gene predicts the wors¬ening of fasting glucose values in a cohort of subjects without diabetes. A population-based study. Diabet Med. 2012; 29: 549-552.
• 11. Talmud PJ, Cooper JA, Gaunt T, et al. Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies. Diabetologia. 2011; 54: 1710-1719.
• 12. Wolfarth B, Rivera MA, Oppert JM, et al. A polymor¬phism in the a2A adrenoceptor gene and endurance ath¬lete status. Med Sci Sports Exerc. 2000; 32: 1709-1712.
• 13. Little J, Higgins JP, Ioannidis JP, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet. 2009; 125: 131-151.
• 14. Druzhevskaya AM, Ahmetov II, Astratenkova IV, et al. Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J Appl Physiol. 2008; 103: 631-634.
• 15. Bouchard C, Daw EW, Rice T, et al. Familial resemblance for VO2max in the sedentary state: the HERITAGE fam¬ily study. Med Sci Sports Exerc. 1998; 30: 252-258.
• 16. Bouchard C, An P, Rice T, et al. Familial aggregation of VO2max response to exercise training: results from the HERITAGE Family Study. J Appl Physiol. 1999; 87: 1003-1008.
• 17. Rice T, Tremblay A, Deriaz O, et al. Genetic pleiotropy for resting metabolic rate with fat-free mass and fat mass: the Quebec Family Study. Obes Res. 1996; 4: 125-131.
• 18. An P, Perusse L, Rankinen T, et al. Familial aggregation of exercise heart rate and blood pressure in response to 20 weeks of endurance training: the HERITAGE family study. Int J Sports Med. 2003; 24: 57-62.
• 19. Goran MI. Genetic influences on human energy expen¬diture and substrate utilization. Behav Genet. 1997; 27: 389-399.
• 20. Williams AG, Folland JP. Similarity of polygenic profiles limits the potential for elite human physical performance. J Physiol. 2008; 586: 113-121.
• 21. Ostrander EA, Huson HJ, Ostrander GK. Genetics of athletic performance. Annu Rev Genomics Hum Genet. 2009; 10: 407-429.
• 22. Sarpeshkar V, Bentley DJ. Adrenergic-beta(2) receptor polymorphism and athletic performance. J Hum Genet. 2010; 55: 479-485.
• 23. Roth SM, Rankinen T, Hagberg JM, et al. Advances in exercise, fitness, and performance genomics in 2011. Med Sci Sports Exerc. 2012; 44: 809-817.
• 24. Kurnik D, Muszkat M, Li C, et al. Genetic variations in the a(2A)-adrenoreceptor are associated with blood pressure response to the agonist dexmedetomidine. Circ Cardiovasc Genet. 2011; 4: 179-187.
• 25. Sawczuk M, Maciejewska-Karłowska A, Cięszczyk P, et al. Ser49Gly and Arg389Gly polymorphisms of the ADRB1 gene and endurance performance. Cent Eur J Biol. 2012; 7: 794-800.
• 26. Sawczuk M, Maciejewska-Karłowska A, Cięsz¬czyk P, et al. Association of the ADRB2 Gly16Arg and Glu27Gln polymorphisms with athlete status. J Sport Sci [in press].
• 27. Gineviciene V, Pranculis A, Jakaitiene A, et al. Genetic variation of the human ACE and ACTN3 genes and their association with functional muscle properties in Lithuanian elite athletes. Medicina (Kaunas). 2011; 47: 284-290.
• 28. Bray MS, Hagberg JM, J Persusse, et al. The human gene map for performance and health-related fitness phenotypes: The 2006-2007 update. Med Sci Sports Exerc. 2009; 41: 35-73.